Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Report Type

Organization

Disposition

Year

Month

Found 40924 record(s)

Req # A-2023-000090

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 23-101662-145.

Organization: Health Canada

12 page(s)
July 2024

Req # A-2023-000319

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 23-102100-548.

Organization: Health Canada

166 page(s)
July 2024

Req # A-2023-000920

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 23-108006-824.

Organization: Health Canada

28 page(s)
July 2024

Req # A-2023-001133

Adverse Drug Reactions (ADRs) for Morphine. Report numbers: 001056184, E2B_00463532, E2B_008003504, 001056381, 001064525. ADR for Heparin. Report number: E2B_06634659. ADRs for Midazolam. Report numbers: 001055123, 001056693, 001060809.

Organization: Health Canada

2013 page(s)
July 2024

Req # A-2023-001169

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 23-109561-522.

Organization: Health Canada

12 page(s)
July 2024

Req # A-2023-001266

Adverse Drug Reactions (ADRs). Report numbers: E2B_00675714, E2B_02977829, E2B_03128456.

Organization: Health Canada

115 page(s)
July 2024

Req # A-2023-001320

Adverse Drug Reactions (ADRs) for Risedronate-35. Report numbers: 000920421, E2B_02181798. ADRs for Omeprazole-20. Report numbers: 000719460, 000935798, 000982924. ADRs for Pantoprazole-40. Report numbers: 000911912, 000940198, E2B_02784902,…

Organization: Health Canada

71 page(s)
July 2024

Req # A-2023-001393

Adverse Drug Reaction (ADR) for . Report number: E2B_01195522. ADR for Zenhale. Report number: 000335842.

Organization: Health Canada

99 page(s)
July 2024

Req # A-2023-001473

Adverse Drug Reactions (ADRs). Report numbers: E2B_ 06770551, E2B_06787144.

Organization: Health Canada

437 page(s)
July 2024

Req # A-2023-001534

Adverse Drug Reactions (ADRs). Report numbers: 001067388, E2B_06778630, 001066676, 001067290, 001071749, 001071491, E2B_06785278, E2B_06800937.

Organization: Health Canada

117 page(s)
July 2024
Date modified: